These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 22050612

  • 1. The role of cortical and hypothalamic histamine-3 receptors in the modulation of central histamine neurotransmission: an in vivo electrophysiology and microdialysis study.
    Flik G, Dremencov E, Cremers TI, Folgering JH, Westerink BH.
    Eur J Neurosci; 2011 Dec; 34(11):1747-55. PubMed ID: 22050612
    [Abstract] [Full Text] [Related]

  • 2. Heterogeneity of histaminergic neurons in the tuberomammillary nucleus of the rat.
    Giannoni P, Passani MB, Nosi D, Chazot PL, Shenton FC, Medhurst AD, Munari L, Blandina P.
    Eur J Neurosci; 2009 Jun; 29(12):2363-74. PubMed ID: 19490084
    [Abstract] [Full Text] [Related]

  • 3. Glutamatergic regulation of brain histamine neurons: In vivo microdialysis and electrophysiology studies in the rat.
    Fell MJ, Flik G, Dijkman U, Folgering JH, Perry KW, Johnson BJ, Westerink BH, Svensson KA.
    Neuropharmacology; 2015 Dec; 99():1-8. PubMed ID: 26100446
    [Abstract] [Full Text] [Related]

  • 4. Interaction Between Brain Histamine and Serotonin, Norepinephrine, and Dopamine Systems: In Vivo Microdialysis and Electrophysiology Study.
    Flik G, Folgering JH, Cremers TI, Westerink BH, Dremencov E.
    J Mol Neurosci; 2015 Jun; 56(2):320-8. PubMed ID: 25820671
    [Abstract] [Full Text] [Related]

  • 5. Thioperamide, a histamine H3 receptor antagonist, increases GABA release from the rat hypothalamus.
    Yamamoto Y, Mochizuki T, Okakura-Mochizuki K, Uno A, Yamatodani A.
    Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):289-98. PubMed ID: 9379777
    [Abstract] [Full Text] [Related]

  • 6. In vivo modulation of rat hypothalamic histamine release by the histamine H3 receptor ligands, immepip and clobenpropit. Effects of intrahypothalamic and peripheral application.
    Jansen FP, Mochizuki T, Yamamoto Y, Timmerman H, Yamatodani A.
    Eur J Pharmacol; 1998 Dec 04; 362(2-3):149-55. PubMed ID: 9874165
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Histamine H3 receptor activation prevents dopamine D1 receptor-mediated inhibition of dopamine release in the rat striatum: a microdialysis study.
    Alfaro-Rodriguez A, Alonso-Spilsbury M, Arch-Tirado E, Gonzalez-Pina R, Arias-Montaño JA, Bueno-Nava A.
    Neurosci Lett; 2013 Sep 27; 552():5-9. PubMed ID: 23896530
    [Abstract] [Full Text] [Related]

  • 10. Brain histamine H3 receptors in rats with portacaval anastomosis: in vitro and in vivo studies.
    Lozeva V, Attila M, Anttila E, Laitinen K, Hippeläinen M, Tuomisto L.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov 27; 358(5):574-81. PubMed ID: 9840427
    [Abstract] [Full Text] [Related]

  • 11. Acute central administration of immepip, a histamine H3 receptor agonist, suppresses hypothalamic histamine release and elicits feeding behavior in rats.
    Chiba S, Itateyama E, Sakata T, Yoshimatsu H.
    Brain Res Bull; 2009 Apr 06; 79(1):37-40. PubMed ID: 19150394
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cortical acetylcholine release elicited by stimulation of histamine H1 receptors in the nucleus basalis magnocellularis: a dual-probe microdialysis study in the freely moving rat.
    Cecchi M, Passani MB, Bacciottini L, Mannaioni PF, Blandina P.
    Eur J Neurosci; 2001 Jan 06; 13(1):68-78. PubMed ID: 11135005
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Regional differential effects of the novel histamine H3 receptor antagonist 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride (GSK189254) on histamine release in the central nervous system of freely moving rats.
    Giannoni P, Medhurst AD, Passani MB, Giovannini MG, Ballini C, Corte LD, Blandina P.
    J Pharmacol Exp Ther; 2010 Jan 06; 332(1):164-72. PubMed ID: 19815811
    [Abstract] [Full Text] [Related]

  • 19. N-substituted piperidinyl alkyl imidazoles: discovery of methimepip as a potent and selective histamine H3 receptor agonist.
    Kitbunnadaj R, Hashimoto T, Poli E, Zuiderveld OP, Menozzi A, Hidaka R, de Esch IJ, Bakker RA, Menge WM, Yamatodani A, Coruzzi G, Timmerman H, Leurs R.
    J Med Chem; 2005 Mar 24; 48(6):2100-7. PubMed ID: 15771452
    [Abstract] [Full Text] [Related]

  • 20. JNJ-10181457, a selective non-imidazole histamine H(3) receptor antagonist, normalizes acetylcholine neurotransmission and has efficacy in translational rat models of cognition.
    Galici R, Boggs JD, Aluisio L, Fraser IC, Bonaventure P, Lord B, Lovenberg TW.
    Neuropharmacology; 2009 Jun 24; 56(8):1131-7. PubMed ID: 19345233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.